Starboard Value, the activist investor pushing for changes at Pfizer, unveiled its goals for another healthcare company — Johnson & Johnson’s consumer spinout Kenvue.
In a …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
In adults with chronic hepatitis B infection receiving viral suppression therapy, coupling an investigational small interfering RNA therapy with an immunomodulator led to substantial declines
Novartis inked a deal to buy MorphoSys for $2.9 billion, in a move that gives the Swiss Big Pharma a cancer drug on the verge
Molecure will oversee the synthesis and evaluation of the entities, selecting promising candidates for further development. Credit: Viacheslav Lopatin / Shutterstock. Molecure has announced a